Australia's most trusted
source of pharma news
Thursday, 18 June 2026
Posted 2 September 2025 AM
Aussie pharma Echo Therapeutics has won a PBS listing for a replacement medicine for Pegasys, ensuring there is continued affordable access to the treatment for Australians living with rare blood cancers.
The good news follows one of the most challenging global shortages of Pegasys supply. The new global owner of the medicine, Pharma&, resumed manufacturing from its Austrian site in 2025, prioritising Europe, where many countries had already run out by early 2025.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.